Biotech start-up disrupts therapeutics discovery using artificial intelligence and DNA sequencing
Dublin, Ireland, October 26th — Nuritas, a start-up using artificial intelligence that is reinventing therapeutics discovery, announced a $3.2 million financing, the highest initial investment ever raised by an Irish company operating in this space. Singapore-based New Protein Capital (NPC), a food and agro-tech investment firm, led the round, which brought together financial supporters from three continents including renowned Silicon Valley investor Ali Partovi.
Using a unique platform that combines artificial intelligence and DNA sequencing, Nuritas discovers particular molecules – called peptides – in natural sources such as food that have scientifically validated health benefits. The company is able to find and unlock these life-changing peptides ten times faster than the prohibitive norm and at a fraction of the cost, thus establishing Nuritas as a game-changer within the health and wellness industry. Nuritas has already developed and patented health-improving ingredients that can address global challenges as broad as inflammation, diabetes, ageing and MRSA, amongst others.
“I was told this was impossible and I decided not to listen,” said founder of Nuritas, Dr. Nora Khaldi, “I built a team who believe in what we do and together we made it happen. We have discovered and patented some incredible life-changing ingredients and we will discover many more.”
Emmet Browne, CEO of Nuritas, said, “We are delighted to collaborate with such like-minded and visionary investors to help us accelerate the discovery revolution that we have already started. We share the same vision of dramatically improving life through combining cutting edge technology with intellect. With this investment we will become even better at speedily unlocking nature’s life-changing secrets that have remained hidden until now and as a result, improve global health.”
“A groundbreaking technology, scalable solutions and the ability to use big data mining to identify new natural health-benefiting ingredients for food and other areas, perfectly fits in the ecosystem of companies NPC has invested and is looking at investing in in the future” says Matthieu Vermersch, Founder of New Protein Capital in Singapore. “Nora Khaldi and Emmet Browne, have chosen a highly innovative path to address profound consumer market challenges. From the very first discussion the harmony between our visions was obvious.” he added.
“The intersection of artificial intelligence and life sciences is an exciting frontier,” said Silicon Valley investor Ali Partovi, who has served as an investor and strategic advisor to Dropbox, Zappos, and Facebook. “The day will come when we won’t remember how therapeutic discovery used to be done without DNA analysis and artificial intelligence.”
For more information, please contact:
Iarla Mongey/John Byrne
+ 353 87 235 6461/ + 353 87 9383852
Drury | Porter Novelli in Dublin
Porter Novelli in Boston
Nuritas was founded by Dr. Nora Khaldi, a mathematician with a PhD in Molecular Evolution and Bioinformatics to revolutionize the discovery of novel, natural and scientifically proven active ingredients that promote and manage our health.
The company’s disruptive computational approach to discovery uses artificial intelligence and DNA analysis to, for the first time ever, rapidly and efficiently provide access to the most health-benefiting components within food called peptides. Nuritas’s patented life-changing peptides provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, skin anti-ageing solutions, and the potential management of blood sugar levels for type 2 diabetics. Put in a nutshell, the company discovers and unlocks ingredients from food sources in a completely unique way, providing natural, sustainable and scientifically proven health solutions.
Nuritas’s dynamic peptides have a vast range of applications in multiple industries including functional and medical foods, pharmaceuticals, dietary supplements, and cosmetics and personal care.
In July 2015, the company received global recognition for the impact its technology will have on the future of food having been awarded the Top Innovation award at the Forbes ‘Reinventing America Summit’.
New Protein Capital is a young investment company focusing on innovative solutions to address food and feed challenges. Today’s life sciences and new technologies finally deliver new ways to redesign food and feed systems from the ground up. The challenge of sustainable agriculture and food represents a major economic issue and is the basis of many promising investment opportunities in developed and emerging countries. NPC is a Singaporean private investment firm. Contact: Matthieu Vermersch – Director – firstname.lastname@example.org, www.newproteincapital.com
To download this Press Release and other media please click here